Refresh

Pfizer Ltd.

Price on BSE   25 Feb,09:34 LIVE
5,125.00
+38.45
(+0.76%)

© 2026 Rediff.com
  • Volume :
  • 179.00
  • Prev Close :
  • 5,086.55
  • Day's H/L (Rs.) :
  • 5,131.05 - 5,067.05
  • 52wk H/L (Rs.) :
  • 5,987.65 - 3,742.90
  • Mkt Cap (Rs. Cr) :
  • 23,421.25
Price on NSE   25 Feb,09:58 LIVE
5,131.90
+47.40
(+0.93%)

© 2026 Rediff.com
  • Volume :
  • 1,508.00
  • Prev Close :
  • 5,084.50
  • Day's H/L (Rs.) :
  • 5,137.20 - 5,070.60
  • 52wk H/L (Rs.) :
  • 5,993.00 - 3,701.00
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Pfizer Ltd.
PE Ratios
30.37
EPS (Rs.)
167.78
Sales (Rs. Cr)
645.03
Face Value (Rs.)
10
Net Profit Margin(%)
33.64
Last Bonus
1:1
Last Dividend(%)
1300
Return on Average Equity
18.2

News for Pfizer Ltd.

Pfizer, Cipla Pact for 4 Brands in India
Cipla and Pfizer India ink exclusive deal to market and distribute 4 Pfizer brands in India. Partnership aims to expand medicine access.
Dec 19, 2025 14:46
UST & IITM Cell: Deep-Tech Startups in Healthcare
UST partners with IIT Madras Incubation Cell to boost healthcare & life sciences startups. Joint programs, mentorship, & funding for innovation.
Dec 17, 2025 14:32
Sudeep Pharma IPO: Rs 268 Cr from Anchor Investors
Sudeep Pharma raises Rs 268.5 crore from anchor investors ahead of its Rs 895 crore IPO opening on November 21. Details inside.
Nov 20, 2025 20:51
Sudeep Pharma IPO Opens: Price Band & Details
Sudeep Pharma IPO price band set at Rs 563-593/share. Public issue opens Nov 21. Details on offer size, objectives, and more.
Nov 19, 2025 21:32
Pfizer Launches Rimegepant for Migraine Treatment
Pfizer introduces Rimegepant ODT in India for migraine treatment, offering rapid, sustained relief without overuse headache risk.
Nov 17, 2025 14:38

More News for Pfizer Ltd. »

News for Pharmaceuticals and health care

Sensex, Nifty Rebound: Market Jumps in Early Trade
Sensex and Nifty rebound in early trade, driven by IT stocks and positive global cues. Key gainers and losers, FII/DII activity.
Feb 25, 2026 09:52
Bajaj Warns of EV Policy Failure in Maharashtra
Rajiv Bajaj criticizes Maharashtra's EV policy, Aaditya Thackeray blames BJP for its collapse. Subsidies slowed dramatically.
Feb 25, 2026 00:20
UP Invest Roadshow in Singapore: Adityanath Outlines Plans
Yogi Adityanath showcases Uttar Pradesh's investment potential at Invest UP Mega Road Show in Singapore, aiming for a $1 trillion economy.
Feb 24, 2026 22:49
Jewellery Retail Revenue to Rise 18% in FY27: Report
Jewellery retail sector projected to post 18% revenue growth in FY27 due to rising bullion prices. Read the full report.
Feb 24, 2026 22:36
AI Data Portal for Biotech Launched
Jitendra Singh launches SUJVIKA, an AI-driven data portal for biotech products. Insights into imports, R&D, and biomanufacturing.
Feb 24, 2026 22:27

More News »

Top News

Sensex, Nifty Rebound: Market Jumps in Early Trade
Sensex and Nifty rebound in early trade, driven by IT stocks and positive global cues. Key gainers and losers, FII/DII activity.
Feb 25, 2026 09:52
Bajaj Warns of EV Policy Failure in Maharashtra
Rajiv Bajaj criticizes Maharashtra's EV policy, Aaditya Thackeray blames BJP for its collapse. Subsidies slowed dramatically.
Feb 25, 2026 00:20
UP Invest Roadshow in Singapore: Adityanath Outlines Plans
Yogi Adityanath showcases Uttar Pradesh's investment potential at Invest UP Mega Road Show in Singapore, aiming for a $1 trillion economy.
Feb 24, 2026 22:49
Jewellery Retail Revenue to Rise 18% in FY27: Report
Jewellery retail sector projected to post 18% revenue growth in FY27 due to rising bullion prices. Read the full report.
Feb 24, 2026 22:36
AI Data Portal for Biotech Launched
Jitendra Singh launches SUJVIKA, an AI-driven data portal for biotech products. Insights into imports, R&D, and biomanufacturing.
Feb 24, 2026 22:27

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com